Perspective Stories
What should I pick up Ispire (USA Stocks:ISPR) or Unusual (USA Stocks:UMAC)?
22 hours ago at Macroaxis By Nico Santiago |
Unusual Machines, trading under the ticker UMAC on the NYSE MKT, is an intriguing player in the shell companies sector. With a current valuation of $12.71 million and a net income from continuing operations showing a loss of $2.4 million, potential investors might find themselves weighing the risks against the opportunities. The company's enterprise value stands at $12.7 million, indicating a relatively small market presence. Continue Reading...
- UMAC Unusual Machines,
- Latest What should I pick up Ispire or Unusual
- UMAC 18.73 8.84
- Low 12.8
- High 19.49
- Volume 62.6 M
- Alpha 4.67
- Beta 0.56
- Return On Equity -0.26
- Return On Asset -0.13
- Profit Margin (1.43) %
- Operating Margin (1.11) %
- Current Valuation 12.71 M
- Shares Outstanding 6.18 M
- Shares Owned By Insiders 27.97 %
- Shares Owned By Institutions 8.32 %
- Number Of Shares Shorted 3.14 K
- Price To Book 0.53 X
- Price To Sales 5.21 X
- Revenue 158.28 M
- EBITDA (2.38 M)
- Net Income (2.38 M)
- Total Debt 114.5 K
- Book Value Per Share 1.92 X
- Cash Flow From Operations (1.78 M)
- Short Ratio 0.02 X
- Earnings Per Share (0.28) X
- Target Price 4.0
- Number Of Employees 3
- Market Capitalization 10.58 M
- Total Asset 1.53 M
- Retained Earnings (3.93 M)
- Working Capital 900.91 K
- Net Asset 1.53 M
- Accumulation Distribution 21.5 M
- Daily Balance Of Power 1.321375
- Rate Of Daily Change 1.89
- Day Median Price 16.15
- Day Typical Price 17.01
- Price Action Indicator 7.01
- Period Momentum Indicator 8.84
- Relative Strength Index 89.57
Macroaxis uses a strict editorial review process to publish stories and blog posts. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Raphi Shpitalnik
By examining key indicators for Academy Sports and Williams, you can assess how market fluctuations impact their stock prices. This analysis can help determine if combining these stocks in a portfolio might reduce overall market risk. Additionally, you might consider a pair trading strategy, where you take a long position in Williams and a short position in Academy Sports.
3 days ago at Macroaxis By Vlad Skutelnik |
By examining key indicators for Nutanix and GigaCloud, you can assess how market fluctuations impact their stock prices and explore potential risk diversification by including both in your portfolio. Pair trading strategies might be useful, such as going long on GigaCloud while shorting Nutanix. For more insights, check out our [pair correlation module](#) on their relationship.
3 days ago at Macroaxis By Raphi Shpitalnik |
Floating rate investments can be a double-edged sword, offering both opportunities and risks. PennantPark Floating Rate Capital Ltd., a player in the asset management industry, presents a unique proposition for investors seeking exposure to financial services. With a net asset base of $1.18 billion and a price-to-book ratio of 1.00X, the company stands on solid ground.
few days ago at Macroaxis By Gabriel Shpitalnik |
Natuzzi SpA, a key player in the furnishings industry, has seen its appeal wane compared to competitors like Bassett Furniture. With a net income showing a loss of 16.2M and a probability of bankruptcy at 42.35%, investors are understandably cautious. Despite a gross profit of 169M, the company's financial health is under scrutiny, especially when juxtaposed with its current valuation of 120.3M.
over a week ago at Macroaxis By Rifka Kats |
In the realm of investing, patience often rewards those who see potential where others see risk. Natuzzi SpA, trading on the NYSE under the ticker NTZ, is catching the eye of savvy investors as a potential gem amid a broader market upswing. Despite a profit margin showing a loss of 0.05, the company's fundamentals suggest a more nuanced picture.
over a week ago at Macroaxis By Raphi Shpitalnik |
Dolby Laboratories' robust market capitalization of 6.8B and a strong institutional ownership of 94.13% suggest a solid foundation, making it a potentially attractive buy for investors seeking stability. However, with a modest five-year return of just 1.09%, those looking for rapid growth might want to consider other options.
Main Takeaways
By examining key indicators for Dolby Laboratories and Skechers, you can assess how market fluctuations impact their stock prices and determine if combining them in a portfolio might reduce overall risk. Pair trading strategies could be employed by taking a long position in Skechers and a short position in Dolby Laboratories.over a week ago at Macroaxis By Vlad Skutelnik |
In investing, patience often pays off. Digimarc, trading on NASDAQ under the ticker DMRC, has recently seen a 3% dip, which might just be the window of opportunity savvy investors are looking for. Despite the dip, the company boasts a robust current ratio of 7.09, indicating strong liquidity and the ability to cover its short-term obligations with ease.
over two weeks ago at Macroaxis By Raphi Shpitalnik |
Considering an investment in Advent Technologies Holdings might be intriguing, especially with its current price hovering near the 52-week low of 1.71. Despite reporting an operating income loss of 57.4M, the company's debt-free balance sheet could provide a cushion for future growth opportunities.
Main Ideas
By examining the fundamental indicators of Advent Technologies and Fusion, you can assess how market fluctuations impact their stock prices and determine if combining them in a portfolio might reduce risk. Pair trading strategies could be employed by taking a long position in Fusion and a short position in Advent Technologies.over three weeks ago at Macroaxis By Gabriel Shpitalnik |
Considering Monte Rosa Therapeutics' robust current ratio of 20.11X and its institutional ownership of 86.74%, the stock may offer a solid liquidity position, but the significant operating income loss of 143.3M raises concerns about its profitability and long-term sustainability.
Key Discoveries
By examining key indicators for Monte Rosa Therapeutics and Lyell, you can assess how market fluctuations impact their stock prices and determine if combining them in a portfolio might reduce risk. Pair trading strategies could be employed by taking a long position in Lyell and a short position in Monte Rosa. For more details, explore our [pair correlation module](#) on their relationship.over three weeks ago at Macroaxis By Aina Ster |